A Comment on the CDC’s Commentary
For two months, the CDC allowed public comments on its draft revision of the opioid prescribing guidelines. They reveal that...
Clinical Trial Meets Patient Advocacy
Clinical trials represent the science in healthcare. It is how we obtain new medical information. But to advance our knowledge...
Why the Opioid Epidemic is Poorly Reported
Few medical crises as large as the opioid epidemic have been so poorly reported. We present the results from our...
Lack of Research Over Long COVID
COVID-19 is now two years old. Along the way, it transitioned from an acute to a chronic condition. In the...
Healthcare Venture Growth Rarely Becomes Profitable
Growth for successful healthcare startups is defined financially. In reality, growth should be defined by clinical improvements, which is less...
Mapping Shifts in Healthcare Labor Markets
For how much we discuss staffing shortages and limited access to care, we have a poor sense of the labor...
The Actual Cost of COVID-19
In between conspiracy and accounting resides the truth about the financial impact of COVID-19. As a systemic risk, it is...
Much Ado About Aduhelm
The data supporting Aduhelm are scant at best. But that did not stop its manufacturer from releasing additional data, showing...
Why Pregnant People Should Get Vaccinated For COVID-19
Pregnancy is often a time of sweet anticipation. But the ongoing pressure to make the right decisions for the health...
Four the Love of Vaccines
The FDA recently received requests to approve a second COVID booster. At the same, it is unsealing documents that were...
Venture Growth is not Healthcare Growth
Growth is a curious thing. We know it when we see it, but we find it hard to replicate. This...
A Fleeting Perception of Data
Data only tells one part of the story when it comes to understanding health policy. The full story is found...
